{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:18:40Z","timestamp":1793319520322,"version":"4.5.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.urolonc.2021.11.013","type":"journal-article","created":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T15:48:49Z","timestamp":1639151329000},"page":"108.e19-108.e25","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["The bladder epicheck test and cytology in the follow-up of patients with non-muscle-invasive high grade bladder carcinoma."],"prefix":"10.1016","volume":"40","author":[{"given":"Francesco","family":"Pierconti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Martini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tonia","family":"Cenci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1132-1761","authenticated-orcid":false,"given":"Vincenzo","family":"Fiorentino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0564-7415","authenticated-orcid":false,"given":"Luca Di","family":"Gianfrancesco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1919-8729","authenticated-orcid":false,"given":"Mauro","family":"Ragonese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Bientinesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernesto","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi M.","family":"Larocca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9129-8479","authenticated-orcid":false,"given":"Marco","family":"Racioppi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pier Francesco","family":"Bassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2021.11.013_bib0001","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.eururo.2019.08.016","article-title":"European association of urology guidelines on non-muscle-invasive bladder cancer (TaT1 and Carcinoma In Situ) - 2019 update","volume":"76","author":"Babjuk","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2021.11.013_bib0002","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.eururo.2015.10.024","article-title":"Economic burden of bladder cancer across the European Union","volume":"69","author":"Leal","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2021.11.013_bib0003","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.urolonc.2017.03.008","article-title":"Clinical comparison of noninvasive urine tests for ruling out recurrent urothelial carcinoma","volume":"35","author":"Lotan","year":"2017","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2021.11.013_bib0004","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1152\/japplphysiol.00238.2010","article-title":"Epigenetic alterations in aging","volume":"109","author":"Gonzalo","year":"2010","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.urolonc.2021.11.013_bib0005","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/modpathol.2014.145","article-title":"Stratification based on methylation of TBX2 and TBX3 into three molecular grades predicts progression in patients with pTa-bladder cancer","volume":"28","author":"Beukers","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1016\/j.urolonc.2021.11.013_bib0006","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/cncy.22152","article-title":"Diagnostic predictive value of the Bladder EpiCheck test in the follow-up of patients with non-muscle-invasive bladder cancer","volume":"127","author":"Trenti","year":"2019","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.urolonc.2021.11.013_bib0007","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/his.13090","article-title":"Iatrogenic changes in the urinary tract","volume":"70","author":"Lopez-Beltran","year":"2017","journal-title":"Histopathology"},{"key":"10.1016\/j.urolonc.2021.11.013_bib0008","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/cncy.21957","article-title":"The risk of malignancy of atypical urothelial cells of undetermined significance in patients treated with chemohyperthermia or electromotive drug administration","volume":"126","author":"Pierconti","year":"2018","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.urolonc.2021.11.013_bib0009","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.prp.2017.07.026","article-title":"Cytological and histological changes in the urothelium produced by electromotive drug administration (EMDA) and by the combination of intravescical hyperthermia and chemotherapy (thermochemotherapy)","volume":"9","author":"Pierconti","year":"2017","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.urolonc.2021.11.013_bib0010","series-title":"TNM Classification of Malignant Tumours","author":"Brierley","year":"2017"},{"key":"10.1016\/j.urolonc.2021.11.013_bib0011","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1097\/00000478-199812000-00001","article-title":"The world health organization\/international society of urological pathology consensus classification of urothelial (transitional cell) neoplasm of the urinary bladder","volume":"22","author":"Epstein","year":"1998","journal-title":"Am. J. Surg. Pathol"},{"key":"10.1016\/j.urolonc.2021.11.013_bib0012","series-title":"The Paris System for Reporting Urinary Cytology","author":"Rosenthal","year":"2016"},{"key":"10.1016\/j.urolonc.2021.11.013_bib0013","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.juro.2017.11.096","article-title":"Efficacy and safety of blue light flexible cystoscopy with hexaminolevulinate in the surveillance of bladder cancer: a phase III, comparative, multicenter study","volume":"199","author":"Daneshmand","year":"2018","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2021.11.013_bib0014","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1007\/s00345-018-2380-x","article-title":"An up-to-date catalog of available urinary biomarkers for the surveillance of non-muscle invasive bladder cancer","volume":"36","author":"Soria","year":"2018","journal-title":"World J Urol"},{"key":"10.1016\/j.urolonc.2021.11.013_bib0015","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.urolonc.2016.06.001","article-title":"Replacing cystoscopy by urine markers in the follow-up of patients with low-risk non-muscleinvasive bladder cancer?-An International Bladder Cancer Network project","volume":"34","author":"Schmitz-Drager","year":"2016","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2021.11.013_bib0016","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.juro.2017.08.091","article-title":"Active surveillance for low risk nonmuscle invasive bladder cancer: a confirmatory and resource consumption study from the BIAS project","volume":"199","author":"Hurle","year":"2018","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2021.11.013_bib0017","doi-asserted-by":"crossref","first-page":"e140","DOI":"10.1016\/j.juro.2016.02.2496","article-title":"Molecular urine cytology\u2014Bladder EpiCheck is a novel molecular diagnostic tool for monitoring of bladder cancer patients","volume":"195","author":"Wasserstrom","year":"2016","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2021.11.013_bib0018","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.euo.2018.06.011","article-title":"Performance of the bladder epicheck methylation test for patients under surveillance for non\u2013muscle-invasive bladder cancer: results of a multicenter, prospective, blinded clinical trial","volume":"1","author":"Witjes","year":"2018","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.urolonc.2021.11.013_bib0019","doi-asserted-by":"crossref","unstructured":"D'Andrea D, Soria F, Zehetmayer S, Gust KM, Korn S, Witjes JA, et al. Diagnostic accuracy, clinical utility and influence on decision making of a methylation urine biomarker test in the surveillance of non\u2013muscle-invasive bladder cancer BJU Int. 2019;123:959-967","DOI":"10.1111\/bju.14673"},{"key":"10.1016\/j.urolonc.2021.11.013_bib0020","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/cncy.22246","article-title":"Comparison of 2 new real-time polymerase chain reaction-based urinary markers in the follow-up of patients with non-muscle-invasive bladder cancer","volume":"128","author":"Trenti","year":"2020","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.urolonc.2021.11.013_bib0021","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12894-016-0147-5","article-title":"The diagnostic accuracy of urine-based tests for bladder cancer varies greatly by patient","volume":"16","author":"Gopalakrishna","year":"2016","journal-title":"BMC Urol"},{"key":"10.1016\/j.urolonc.2021.11.013_bib0022","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/cyt.12050","article-title":"Ruffion A. Diagnostic terminology for urinary cytology reports including the new subcategories \u2018atypical urothelial cells of undetermined significance\u2019 (AUC-US) and \u2018cannot exclude high grade\u2019 (AUC-H)","volume":"25","author":"Piaton","year":"2014","journal-title":"Cytopathology"},{"key":"10.1016\/j.urolonc.2021.11.013_bib0023","doi-asserted-by":"crossref","first-page":"100","DOI":"10.4103\/0974-7796.68857","article-title":"Diagnostic significance of atypical category in the voided urine samples: A retrospective study in a tertiary care center","volume":"2","author":"Mokhtar","year":"2010","journal-title":"Urol Ann"},{"key":"10.1016\/j.urolonc.2021.11.013_bib0024","first-page":"23","article-title":"Malignant atypical cell in urine cytology: a diagnostic dilemma","volume":"15","author":"Bhatia","year":"2006","journal-title":"Cytojournal"},{"key":"10.1016\/j.urolonc.2021.11.013_bib0025","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/bju.12516","article-title":"Hakimi AA et al Reflex fluorescence in situ hybridization assay for suspicious urinary cytology in patients with bladder cancer with negative surveillance cystoscopy","volume":"114","author":"Kim","year":"2014","journal-title":"BJU Int"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143921005111?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143921005111?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:23:28Z","timestamp":1761042208000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143921005111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S1078143921005111"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2021.11.013","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The bladder epicheck test and cytology in the follow-up of patients with non-muscle-invasive high grade bladder carcinoma.","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2021.11.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}